Are you Dr. Kutteh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
701 10th St Se
Hpcc 3rd Floor
Cedar Rapids, IA 52403Phone+1 319-363-8303Fax+1 319-364-4659
Summary
- Dr. Leila Kutteh, MD is an oncologist in Cedar Rapids, Iowa. She is currently licensed to practice medicine in Iowa, Ohio, and Maryland. She is affiliated with Mercy Medical Center - Cedar Rapids, UnityPoint Health - St. Luke's Hospital, and Mercy Iowa City.
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1995
- University of Maryland Medical Center Midtown CampusResidency, Internal Medicine, 1988 - 1991
- American University of Beirut Faculty of MedicineClass of 1986
Certifications & Licensure
- IA State Medical License 1999 - 2026
- OH State Medical License 1992 - 2001
- MD State Medical License 1989 - 1993
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Publications & Presentations
PubMed
- 3929 citationsTrastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancerEdward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer
The New England Journal of Medicine. 2005-10-20 - 119 citationsRadiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831Michele Y. Halyard, Thomas M. Pisansky, Amylou C. Dueck, Vera J. Suman, Lori J. Pierce
Journal of Clinical Oncology. 2009-06-01 - 37 citationsSoluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2‐positive breast cancer receiving chemotherapy with or without trastuzumab: Results...Alvaro Moreno-Aspitia, David W. Hillman, Stephen Dyar, Kathleen S. Tenner, Julie R. Gralow
Cancer. 2013-08-01